普洛药业与德睿智药开展CDMO项目的长期合作

Core Viewpoint - Pro Pharmaceutical (000739) has signed a strategic cooperation framework agreement with Hangzhou Derui Zhiyao Technology Co., Ltd. to engage in long-term collaboration on CDMO projects, enhancing its competitive edge in the CDMO business [1]. Group 1 - The strategic cooperation agreement establishes a partnership based on mutual benefits and complementary advantages between Pro Pharmaceutical and Derui Zhiyao [1]. - The collaboration aims to promote the application of relevant technologies in Pro Pharmaceutical's CDMO projects, from process development to large-scale production [1]. - This partnership is expected to facilitate the expansion of Pro Pharmaceutical's CDMO business, thereby improving its competitiveness in the industry [1].